AFT's Maxigesic tablet sales more than triple in 2017

AFT's Maxigesic tablet sales more than triple in 2017
Paul McBeth
By Paul McBeth May 12 (BusinessDesk) - AFT Pharmaceuticals more than tripled sales of its flagship Maxigesic tablet in the 2017 financial year and anticipates more growth as it taps new markets.  The Auckland-based drug maker sold 74 million tablets in the year ended March 31, up from 22 million tablets a year earlier, it said in a statement. The company will report earnings next week, and in March said it expected to generate annual sales of between $69 million and $71 million, up from $65.8 million a year earlier.  The increase in Ma...